Biogen (BIIB) Other Non-Current Assets (2009 - 2026)
Biogen's Other Assets was $659.8 million in Q3 2026, down 9.6% from $729.7 million a year earlier and down 20.7% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Other Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Other Assets at Biogen came in at $750.6 million, up 33.9% from FY2024.
- Other Assets shows a five-year compound annual growth rate of -23.7% (FY2020 to FY2025).
- In earlier years, Other Assets was $560.5 million in FY2024 (-24.8%), $745 million in FY2023 (-51.3%), $1.53 billion in FY2022 (-21.2%) and $1.94 billion in FY2021 (-33.1%).
- The Q3 2026 figure marks the lowest quarterly Other Assets since Q2 2025.
- Compared with a year earlier, Other Assets was higher in four of the last eight quarters, with growth averaging 7.3%.
- The best year-over-year quarter for Other Assets over five years was Q1 2026 (growth of 39.1%); the worst was Q3 2023 (a decline of 53.2%).
- Per Business Quant data, BIIB's Other Assets in the three quarters before Q3 2026 was $831.8 million (Q2 2026), $777.5 million (Q1 2026) and $750.6 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn | 659.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 659.80 Mn |
| Jun 30, 2026 | 831.80 Mn |
| Mar 31, 2026 | 777.50 Mn |
| Dec 31, 2025 | 750.60 Mn |
| Sep 30, 2025 | 729.70 Mn |
| Jun 30, 2025 | 637.70 Mn |
| Mar 31, 2025 | 559.10 Mn |
| Dec 31, 2024 | 560.50 Mn |
| Sep 30, 2024 | 631.40 Mn |
| Jun 30, 2024 | 681.50 Mn |
| Mar 31, 2024 | 697.60 Mn |
| Dec 31, 2023 | 745.00 Mn |
| Sep 30, 2023 | 754.60 Mn |
| Jun 30, 2023 | 1.10 Bn |
| Mar 31, 2023 | 1.38 Bn |
| Dec 31, 2022 | 1.53 Bn |
| Sep 30, 2022 | 1.61 Bn |
| Jun 30, 2022 | 1.50 Bn |
| Mar 31, 2022 | 1.77 Bn |
| Dec 31, 2021 | 1.94 Bn |
API Access
Biogen Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();